To evaluate the efficacy and toxicity of cyclosporin A (CsA) in the treatment of patients with psoriatic arthritis (PsA)
Twelve patients with psoriatic arthritis (PsA) were treated with low doses of cyclosporine A (CsA) (...
Cyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psor...
Twelve patients with psoriatic arthritis (PsA) and very active articular disease resistant to conven...
To evaluate the efficacy and toxicity of cyclosporin A (CsA) in the treatment of patients with psori...
Cyclosporin A (CsA) has been proved to be effective in the treatment of severe cutaneous psoriasis a...
Psoriatic arthropathy (PsA) is an inflammatory arthropathy associated with skin or nail psoriasis wi...
To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST)...
BACKGRO UND: The SYNER GY Study is an observational, multicenter Italian study, conducted in patient...
OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of long-term treatmen...
The SYNERGY study is an observational, multicenter Italian study, conducted in patients with diagnos...
The results of this open trial confirm that CSA is well tolerated by patients with PsA and suggest t...
Cyclosporine A, a unique immunomodulatory agent, has been used increasingly over the last 5 years in...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
To evaluate the levels of serum chemokines in patients with psoriatic arthritis (PsA) before and dur...
Cyclosporin A (CYA) has recently attracted the attention of the dermatologists with regard to its us...
Twelve patients with psoriatic arthritis (PsA) were treated with low doses of cyclosporine A (CsA) (...
Cyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psor...
Twelve patients with psoriatic arthritis (PsA) and very active articular disease resistant to conven...
To evaluate the efficacy and toxicity of cyclosporin A (CsA) in the treatment of patients with psori...
Cyclosporin A (CsA) has been proved to be effective in the treatment of severe cutaneous psoriasis a...
Psoriatic arthropathy (PsA) is an inflammatory arthropathy associated with skin or nail psoriasis wi...
To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST)...
BACKGRO UND: The SYNER GY Study is an observational, multicenter Italian study, conducted in patient...
OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of long-term treatmen...
The SYNERGY study is an observational, multicenter Italian study, conducted in patients with diagnos...
The results of this open trial confirm that CSA is well tolerated by patients with PsA and suggest t...
Cyclosporine A, a unique immunomodulatory agent, has been used increasingly over the last 5 years in...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
To evaluate the levels of serum chemokines in patients with psoriatic arthritis (PsA) before and dur...
Cyclosporin A (CYA) has recently attracted the attention of the dermatologists with regard to its us...
Twelve patients with psoriatic arthritis (PsA) were treated with low doses of cyclosporine A (CsA) (...
Cyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psor...
Twelve patients with psoriatic arthritis (PsA) and very active articular disease resistant to conven...
DOI
Add to ORKG